Substance(s)

• (Z)-3-(3-(3,5-bis(Trifluormethyl)phenyl-1H-1,2,4-triazol-1-yl)-N'-(pyrazin-2-yl)acrylhydrazid
• 2-methyl-1-[(4-[6-(trifluoromethyl)pyridin-2-yl]-6-{[2-(trifluoromethyl)pyridin-4-yl]amino}-1,3,5-triazin-2-yl)amino]propan-2-ol methanesulfonate
• Acide 4-{[(2R,3S,4R,5S)-4-(4-chloro-2-fluoro-phényl)-3-(3-chloro-2-fluoro-phényl)-4-cyano-5-(2,2-diméthyl-propyl)-pyrrolidin-2-carbonyl]-amino}-3-méthoxybenzoïque
• Cytarabine
• Devimistat
• Idelalisib
• Liposomal cytarabine-daunorubicin
• Quizartinib dihydrochloride
• Sapacitabine
• Trans N1-((1R,2S)-2-phénylcyclopropyl)-cyclohexan-1, 4-diamine bis-chlorhydrate
• monoclonal IgG1 antibody directed against human Bst1/CD157 antigen

Nom(s) commercial(aux)

• DACOGEN
• VIDAZA